CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 128 enrolled
Drug / intervention
Deep parasternal intercostal plane blockprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06895876
NCT06895876N/ACompleted

Deep Parasternal Intercostal Plane Block : Effect on the Quality of Postoperative Recovery After Cardiac Surgery

Institute Arnault Tzanck, France·interventional·Posted Mar 26, 2025·Updated May 7, 2026

In Brief

A clinical study evaluating Deep parasternal intercostal plane block for Nerve Block. Completed, enrolled 128 participants across 1 site.

Detailed Summary

Cardiac surgery is a source of severe post operative pain witch can cause major respiratory complications due to non optimal post operative rehabilitation. Multimodal analgesia provides acceptable pain control , but does not seem sufficient during coughing or mobilization. The use of morphine also exposes patients to side effects (nausea, vomiting, pruritus, respiratory depression, chronic pain, ileus). Bleeding and hemodynamic risks of peridural and spinal aneshesia limits their use. The postoperative efficacy of deep parasternal intercostal plane block has not yet been evaluated sufficiently. The aim of this study is to evaluate the efficacity of TTMPB on the quality of postoperative recovery after cardiac surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNerve Block
CountriesFrance
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedMar 26, 2025
Enrollment StartAug 10, 2022
Primary CompletionOct 12, 2022
Study CompletionJun 15, 2025
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 1.3 years ago

Interventions

Deep parasternal intercostal plane blockprocedure

The block is performed bilaterally in the 4th intercostal space. The probe is placed in the latero-median axis and a needle is placed latero-medially between the intercostal and transverse thoracic muscle. The solution is then injected under ultrasound control